Opinion
Thrombolytic therapy versus primary percutaneous coronary intervention: role of clinical pharmacist
Saadoun O. El-Mezughi, Tarek AlZawawy, Nawal KhalafAlla
In
conclusion:
ST-elevation myocardial infraction (ST-EMI) is a very serious condition. Patients should be admitted to a coronary
care or intensive care unit capable for extensive monitoring. Management of
ST-EMI requires complex early and long-term post-reperfusion pharmacotherapy.
Cardiology clinical pharmacists can play a crucial role in care of ST-EMI
patients, independently and as a multidisciplinary team to ensure that safe
early reperfusion is achieved and maintained. Clinical pharmacist can play a vital role in optimization of drug therapy
through sharing the medical team in daily patient-care rounds, reviewing
prescribed medications to cardiac patients, counseling and offering advice on
optimal drug use and providing valid pharmaceutical information.